Search for: "State v. D. A. R." Results 281 - 300 of 16,106
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Jul 2023, 9:01 pm by renholding
As one commenter stated: “In the hours and days following a cybersecurity breach, companies must quickly and efficiently contain, minimize, and remedy any damage or loss resultin [read post]
26 Jul 2023, 9:31 am by Victor Zhang
Co-sponsors of the bill include Senators Dick Durbin (D-IL), John Kennedy (R-LA), and Roger Wicker (R-MS). [read post]
25 Jul 2023, 12:15 pm
La note conceptuelle de l'événement de cette année et de plus amples informations sont disponibles sur le site web du Forum.Tous les acteurs concernés de toutes les régions sont invités à s’inscrire.INSCRIPTIONS OUVERTESParticipez au Forum pour partager des expériences et vous informer sur les dernières initiatives visant à promouvoir une conduite responsable des entreprises… [read post]
19 Jul 2023, 9:05 pm by renholding
Federal and state rules already require reporting of most Scope 1 emissions, including the pollution from power plants that are others’ Scope 2 emissions. [read post]
17 Jul 2023, 12:32 pm by Marketing
Decisions from the Federal Circuit Court can be appealed to the Supreme Court of the United States. [read post]
17 Jul 2023, 1:38 am by Florian Mueller
"While not specifically related to the EU proposal, I'd also like to quote the former Chief Judge of the United States Court of Appeals for the Federal Circuit, Randall R. [read post]
10 Jul 2023, 2:25 am by Matrix Law
R (on the application of Afzal) v Secretary of State for the Home Department, heard 7th June 2023. [read post]
8 Jul 2023, 11:41 pm by Aaron Moss
A Matter of Perspective As another example, consider Steinberg v. [read post]
Although the Court of Appeal was clear, in Neurim v Generics [2020] EWCA Civ 793, that deciding to uphold the lower court’s decision not to grant a pharmaceutical patent PI was based on the specific facts of that case, the Patents Court has subsequently refused two further pharmaceutical PIs (Neurim v Teva [2022] EWHC 954 (Pat) and [2022] EWHC 1641(Pat), and Novartis v Teva [2022] EWHC 959 (Ch)). [read post]